ATE297985T1 - Orale impfstoffe gegen yersinia pestis infektionen - Google Patents

Orale impfstoffe gegen yersinia pestis infektionen

Info

Publication number
ATE297985T1
ATE297985T1 AT95910622T AT95910622T ATE297985T1 AT E297985 T1 ATE297985 T1 AT E297985T1 AT 95910622 T AT95910622 T AT 95910622T AT 95910622 T AT95910622 T AT 95910622T AT E297985 T1 ATE297985 T1 AT E297985T1
Authority
AT
Austria
Prior art keywords
transforming
constructs
microorganisms
vaccines against
yersinia pestis
Prior art date
Application number
AT95910622T
Other languages
English (en)
Inventor
Richard William Titball
Ethel Diane Williamson
Sophie Emma Clare Leary
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE297985T1 publication Critical patent/ATE297985T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95910622T 1994-03-08 1995-03-06 Orale impfstoffe gegen yersinia pestis infektionen ATE297985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9404577A GB9404577D0 (en) 1994-03-08 1994-03-08 Vaccine compositions
PCT/GB1995/000481 WO1995024475A1 (en) 1994-03-08 1995-03-06 Vaccine compositions

Publications (1)

Publication Number Publication Date
ATE297985T1 true ATE297985T1 (de) 2005-07-15

Family

ID=10751562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910622T ATE297985T1 (de) 1994-03-08 1995-03-06 Orale impfstoffe gegen yersinia pestis infektionen

Country Status (8)

Country Link
EP (1) EP0753061B1 (de)
JP (1) JPH09511139A (de)
AT (1) ATE297985T1 (de)
AU (1) AU1853995A (de)
CA (1) CA2184902A1 (de)
DE (1) DE69534280T2 (de)
GB (1) GB9404577D0 (de)
WO (1) WO1995024475A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615022D0 (en) * 1996-07-17 1996-09-04 Mini Agriculture & Fisheries Vaccine preparations
US20070043215A1 (en) 1996-08-27 2007-02-22 Heath David G Recombinant f1-v plague vaccine
WO2005023205A2 (en) * 2003-03-07 2005-03-17 University Of Massachusetts Compositions and methods for yersinia pestis treatment
WO2006110881A2 (en) * 2005-04-12 2006-10-19 Michigan State University Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins

Also Published As

Publication number Publication date
DE69534280T2 (de) 2006-03-16
WO1995024475A1 (en) 1995-09-14
CA2184902A1 (en) 1995-09-14
EP0753061A1 (de) 1997-01-15
AU1853995A (en) 1995-09-25
DE69534280D1 (de) 2005-07-21
JPH09511139A (ja) 1997-11-11
EP0753061B1 (de) 2005-06-15
GB9404577D0 (en) 1994-04-20

Similar Documents

Publication Publication Date Title
CY1122869T1 (el) Πολυπεπτιδικα εμβολια για ευρεια προστασια εναντι υπερλοιμογονων μηνιγγιτιδοκοκκικων γενεαλογικων σειρων
Saxena et al. Pre-existing immunity against vaccine vectors–friend or foe?
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DE69625802D1 (de) Impfstoffe gegen die pest
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
HU9904549A (en) Vaccines
ATE440861T1 (de) Immunisierung gegen chlamydia pneumoniae
NO20075901L (no) Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse
TR200403064T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler.
Vanloubbeeck et al. The immunology of Leishmania infection and the implications for vaccine development
ATE13741T1 (de) Ein spezifisches antigen enthaltender impfkomplex und ihn enthaltender impfstoff.
WO2002034773A3 (en) Streptococcal genes
DE602004028029D1 (en) Rwendung
DE69515340D1 (de) Impfstoff gegen mycobakterielle infektionen
ATE297985T1 (de) Orale impfstoffe gegen yersinia pestis infektionen
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
ATE462779T1 (de) Nukleinsäurefreie ghost zusammensetzungen
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
AR019785A1 (es) Pestivirus no diseminantes
Mukkur et al. Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and calves
DE69433760D1 (de) Gegen mumps impfstoff, das ein virus des jeryl-lynn stammes enthält
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
WO2005056769A3 (en) Orally-administered live bacterial vaccines for plague

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties